Open access · CC0
via OpenAlex
Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life
Kathleen E. Fischer, Jonathan Gelfond, Vanessa Y. Soto, Chul Ju Han, Shinichi Someya, Arlan Richardson, Steven N. Austad
PLoS ONE · 2015 · ▲ 75 citations
Abstract
mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition), an mTOR inhibitor, has been shown to extend lifespan in a range of model organisms. It has been reported to extend lifespan in multiple strains of mice, administered chronically or acutely early or late in life. The ability of rapamycin to extend health (healthspan(definition)) as opposed to life is less well documented. To assess the effects chronic rapamycin treatment on healthspan, enteric rapamycin was given to male and female C57BL/6J mice starting at 4 months of age and continued throughout life. Repeated, longitudinal assessments of health in individual animals were made starting at 16 months of age (=12 months of treatment) until death. A number of health parameters were improved (female grip strength, female body mass and reduced sleep fragmentation in both sexes), others showed no significant difference, while at least one (male rotarod performance) was negatively affected. Rapamycin treatment affected many measures of health in a highly sex-specific manner. While sex-specific phenotypic effects of rapamycin treatment have been widely reported, in this study we document sex differences in the direction of phenotypic change. Rapamycin-fed males and females were both significantly different from controls; however the differences were in the opposite direction in measures of body mass, percent fat and resting metabolic rate, a pattern not previously reported.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0126644
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Fischer, K.E., Gelfond, J., Soto, V.Y., Han, C.J., Someya, S., Richardson, A., & Austad, S.N. (2015). Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0126644
Vancouver
Fischer KE, Gelfond J, Soto VY, Han CJ, Someya S, Richardson A, et al. Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life. PLoS ONE. 2015. doi:10.1371/journal.pone.0126644.
BibTeX
@article{kathleen2015Health,
title = {Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life},
author = {Kathleen E. Fischer and Jonathan Gelfond and Vanessa Y. Soto and Chul Ju Han and Shinichi Someya and Arlan Richardson and Steven N. Austad},
journal = {PLoS ONE},
year = {2015},
doi = {10.1371/journal.pone.0126644},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The journals of gerontology. Series A, Biological sciences and medical sciences 2026
Citation only
The association of frailty with age and lifespan in mice differs by strain and sex.
The Journals of Gerontology Series A 2026
Open access · CC-BY
The association of frailty with age and lifespan in mice differs by strain and sex
International Journal of Physical Education Sports and Health 2021
Open access · OA
Body mass index in relation to level of physical exercise of teacher education students
Taipei Medical University 2021
Open access · US-GOV
The Relationships of Resistance Exercise, Walking, Myokine Secretion, Sarcopenia, Muscle Loss, Quality of Life, and Predictors in Cancer Patients Receiving Chemoradiotheray
Innovation in Aging 2019
Open access · CC-BY
MACHINE LEARNING ANALYSIS OF MOUSE FRAILTY FOR PREDICTION OF BIOLOGICAL AGE AND LIFE EXPECTANCY
Freeman-Sheldon Research Group, Inc. 1972
Open access · US-GOV